NCT01846312View on ClinicalTrials.gov

An Observational Study to Assess Longitudinal Variation of Immune Biomarkers in Subjects at Risk for Development of Type 1 Diabetes

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
DiabetesDiabetes Mellitus, Type 1
Interventions
OTHER

No treatment given

The participants will not receive any treatment.

Trial Locations (1)

08540

Novo Nordisk Clinical Trial Call Center, Princeton

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT01846312 - An Observational Study to Assess Longitudinal Variation of Immune Biomarkers in Subjects at Risk for Development of Type 1 Diabetes | Biotech Hunter | Biotech Hunter